Innovate UK

Innovate U.K. is a NPO that offers funding services to support science and technology innovations. The organization offers services and information on births, deaths, marriages, business, self-employed, childcare, parenting, citizenship, law, disabled persons, transportation, education, environment, housing, money, tax, travel, immigration, and jobs. Innovate U.K. is based in Swindon.

Mike Biddle

Programme Director of Industrial Strategy Challenge Fund

Will Drury

Executive Director, Digital and Technologies

Paul Gadd

Deputy Director

Dr. Tom Jenkins

Deputy Director

Scott James O'Brien

Director, Innovation Finance

Nigel Walker

Deputy Director, Lending and Investor Partnerships

Dave Wilkes

Director of Innovation Ecosystem

Past deals in Personal Health

Z-PULSE

Grant in 2025
Z-PULSE, a spin-off from the University of Surrey, creates wearable health sensors that run on their own power.

SEQUENTIAL

Grant in 2025
Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing Co™ Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claims substantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and testing, to analysis, and support on formulation development and certification. And it’s all done in vivo! Sequential Skin on the other hand is revolutionising skin health with the world's first consumer skin microbiome test. Formed of an award-winning team with a mission to empower individuals to make better-informed decisions about their skin health. (www.sequentialskin.com) Sequential is the product of the team's combined expertise in epigenetics, genetics, and microbiome research. Supported by Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, CSB, and is a resident company of Johnson & Johnson Innovation – JLABS. Seen in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo.

MedicSen

Grant in 2024
MedicSen is a start-up dedicated to health care, to technological innovation as a key tool. With several projects under mind, we have launched the most ambitious of them all, GlycSen. It is designed for intelligent treatment of insulin dependent diabetes device.

SleepCogni

Grant in 2024
SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.

Holly Health

Seed Round in 2023
Holly Health is a digital health coaching application that assists individuals in transforming their health intentions into actionable daily habits for improved mental and physical wellbeing. Utilizing proprietary AI systems, the service mimics the support of a human health coach, offering personalized guidance to users. The application features tools such as habit reminders, tailored health content, and progress tracking, all aimed at helping users establish and maintain healthier routines. Recognized as one of the top health apps for weight management, stress reduction, wellness, and sleep, Holly Health achieved a notable evaluation score of 89% from ORCHA, a leading health app assessment organization. Launched internationally in Summer 2021, the company aims to support five million individuals by 2025 and is actively partnering with primary care practices in the UK, having established over 100 collaborations to date.

Holly Health

Seed Round in 2023
At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.

Jude

Grant in 2023
Jude is a healthcare company focused on addressing bladder health issues and raising awareness about incontinence. The organization offers a range of services that include expert advice from medical professionals through social media, virtual seminars, and private chat options. Additionally, Jude provides health products designed to assist individuals in managing their bladder health effectively. By combining educational resources with accessible support, Jude aims to empower individuals to understand their medical conditions and pursue solutions for a leak-free life.

ZiO Health

Grant in 2023
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.

BERRI

Grant in 2023
BERRI is a digital toolkit that can identify, track, and support children's psychological needs, as well as provide personalized reports to their carers. It analyses children and young people's needs in areas such as behavior, emotional well-being, relationships, risk, and indicators of underlying disorders.

Juniver

Grant in 2023
Juniver offers specialized care and support for individuals recovering from eating disorders through a neuroscience-based recovery program. The company provides an on-demand platform that includes practical tools and habit-formation principles, aimed at helping users manage cravings and urges. By fostering a supportive community, Juniver facilitates long-term recovery, addressing the complexities of disordered eating in a comprehensive manner.

patientMpower

Grant in 2023
PatientMpower specializes in remote monitoring solutions aimed at patients with chronic diseases, particularly those with respiratory conditions. The company develops applications that integrate with devices such as spirometers and pulse oximeters, allowing patients to conduct measurements at home. These devices connect to a smartphone application, which transmits real-time data to healthcare providers. This integration supports healthcare professionals in delivering high-quality care and enhances patient outcomes by facilitating continuous monitoring. Additionally, the data collected contributes to research efforts aimed at improving treatment options for chronic conditions.

BelleVie

Grant in 2022
BelleVie is a provider of personal care services aimed at supporting individuals in their daily lives while enabling them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. BelleVie operates with a unique model of self-managing teams, inspired by the successful Buurtzorg approach from the Netherlands, which emphasizes fulfilling careers in care and fosters meaningful relationships within the care ecosystem. The company utilizes its proprietary Wellbeing OS technology platform to facilitate its operations, funded through a monthly subscription model. BelleVie’s vision focuses on creating a society where every individual is valued and supported, ensuring that care providers and recipients alike benefit from reciprocal and enriching interactions.

Transdermal Diagnostics

Grant in 2022
Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes.

On The Mend

Pre Seed Round in 2022
On The Mend is a mobile platform to help people manage their physical rehab. We are currently working towards creating a unique platform with a broad application beyond orthopaedic surgery.

SEQUENTIAL

Grant in 2022
Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing Co™ Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claims substantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and testing, to analysis, and support on formulation development and certification. And it’s all done in vivo! Sequential Skin on the other hand is revolutionising skin health with the world's first consumer skin microbiome test. Formed of an award-winning team with a mission to empower individuals to make better-informed decisions about their skin health. (www.sequentialskin.com) Sequential is the product of the team's combined expertise in epigenetics, genetics, and microbiome research. Supported by Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, CSB, and is a resident company of Johnson & Johnson Innovation – JLABS. Seen in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo.

CONNECT Care

Grant in 2022
We already know that upto 50% of patients struggle to take their medicines – patients are not well-supported and too often it remains a hidden problem until it's too late. CONNECT Care want to change that: empowering patients and, at the same time, using data-driven insights to enable clinicians and carers to provide better support in real-time.

SleepCogni

Debt Financing in 2021
SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.

CONNECT Care

Grant in 2021
We already know that upto 50% of patients struggle to take their medicines – patients are not well-supported and too often it remains a hidden problem until it's too late. CONNECT Care want to change that: empowering patients and, at the same time, using data-driven insights to enable clinicians and carers to provide better support in real-time.

Go Jauntly

Grant in 2020
Go Jauntly is a health and wellness company focused on enhancing walking, mobility, and outdoor adventures through its community-based application. The app, available for free on iOS and Android, facilitates the discovery of walking routes, offers navigation photographs, and allows users to document and share their experiences. With 450,000 downloads and over 40,000 active monthly users, Go Jauntly has generated over £500,000 in revenue through partnerships with organizations such as Boots Walgreen Alliance, Transport for London, and various local authorities across the UK. The platform encourages users to explore their surroundings, improve their physical health, and engage with nature, promoting a healthier lifestyle. Go Jauntly has garnered multiple accolades, including a bronze award in The Anthem Awards 2022 and recognition as App of the Day and Editor’s Choice by Apple. The company has also received funding and grants from various organizations, highlighting its innovative approach to promoting physical activity and community engagement.

Gendius

Grant in 2019
Gendius Ltd. is a company based in Macclesfield, United Kingdom, founded in 2011 by Chris Genders and Rory Cameron. It specializes in developing app-based solutions for individuals living with diabetes. The company's flagship product, Intellin, is an innovative platform that leverages a user’s clinical history to identify personal high-risk areas for diabetes-related complications. By focusing on these specific risks, Intellin guides users through clinically validated tasks and measures aimed at slowing the progression of their condition, thereby enhancing their quality of life and management of diabetes.

Healum

Grant in 2019
Healum is a developer of connected software and applications aimed at enhancing self-management for individuals with long-term health conditions. The company's AI-powered platform offers personalized care and support by leveraging data-driven insights and evidence-based behavioral interventions. Healum's tools enable patients to effectively monitor and understand both their physical and mental health, while also providing healthcare professionals with the means to assist patients in managing chronic conditions. This approach promotes a collaborative environment where patients receive customized support tailored to their unique health needs.

COHESION Medical

Grant in 2019
COHESION Medical Ltd. is a Connected Citizen Health company building the safest, smartest and most streamlined health system in the world, improving global population health and wellness. COHESION.OS is making citizens more empowered, services more efficient and sciences more innovative.

COHESION Medical

Grant in 2018
COHESION Medical Ltd. is a Connected Citizen Health company building the safest, smartest and most streamlined health system in the world, improving global population health and wellness. COHESION.OS is making citizens more empowered, services more efficient and sciences more innovative.

Go Jauntly

Grant in 2018
Go Jauntly is a health and wellness company focused on enhancing walking, mobility, and outdoor adventures through its community-based application. The app, available for free on iOS and Android, facilitates the discovery of walking routes, offers navigation photographs, and allows users to document and share their experiences. With 450,000 downloads and over 40,000 active monthly users, Go Jauntly has generated over £500,000 in revenue through partnerships with organizations such as Boots Walgreen Alliance, Transport for London, and various local authorities across the UK. The platform encourages users to explore their surroundings, improve their physical health, and engage with nature, promoting a healthier lifestyle. Go Jauntly has garnered multiple accolades, including a bronze award in The Anthem Awards 2022 and recognition as App of the Day and Editor’s Choice by Apple. The company has also received funding and grants from various organizations, highlighting its innovative approach to promoting physical activity and community engagement.

Pactster

Grant in 2018
Pactster is a social fitness platform offering channels of fitness videos for health specific needs along with motivational and community features to help people use exercise for both preventative and restorative health.

Accurx

Grant in 2018
AccuRx is a healthcare communication platform that facilitates seamless interaction between patients and healthcare professionals. The platform enables users to send SMS messages, conduct video consultations, manage appointment bookings, and distribute medical surveys. It also supports the organization of outpatient clinics, virtual wards, and follow-up pathways, enhancing the overall efficiency of primary care. With its adoption by 98% of GP practices and 50% of NHS trusts, AccuRx plays a crucial role in improving communication and collaboration in patient care, ensuring that all parties involved can connect easily and effectively.

GripAble

Grant in 2017
GripAble Ltd. designs and develops digital therapy devices aimed at improving rehabilitation for individuals with movement impairments such as stroke, arthritis, cerebral palsy, and trauma. Founded in 2017 and based in London, the company offers a portable, wireless handgrip device that connects to a mobile application. This application allows users to engage with therapy games while providing assessment and training for hand and arm functions. GripAble's innovative approach focuses on making therapy more accessible and engaging for patients, enabling them to practice essential daily tasks in a fun and motivating way. By combining hardware and software, GripAble addresses the needs of over 500 million people worldwide who face challenges with arm mobility, facilitating self-training both in clinical settings and at home.

SleepCogni

Grant in 2017
SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.

Current Health

Grant in 2017
Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Sky Medical Technology

Grant in 2015
Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatory conditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.